BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6189239)

  • 1. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
    Rosove MH; Hocking WG; Harwig SS; Perloff JK
    Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
    Rosove MH; Frank HJ; Harwig SS
    Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
    Kaplan KL; Nossel HL; Drillings M; Lesznik G
    Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
    Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
    Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
    Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
    Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
    Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
    Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
    Douglas JT; Lowe GD; Forbes CD; Prentice CR
    Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anticoagulant mixtures on BTG and PF4 levels.
    Randi ML; Fabris F; Casonato A; Girolami A
    Thromb Haemost; 1981 Aug; 46(2):569. PubMed ID: 6171043
    [No Abstract]   [Full Text] [Related]  

  • 10. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
    Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
    Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Thromboglobulin and platelet-factor 4 in patients with cancer: correlation with the stage of disease and the effect of chemotherapy.
    Al-Mondhiry H
    Am J Hematol; 1983 Apr; 14(2):105-11. PubMed ID: 6188373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
    Lokiec F; Najean Y
    Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
    Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
    Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of polyethylene glycol to radioimmunoassays used in haemostasis.
    Woodhams BJ; Kernoff PB
    Thromb Res; 1983 Feb; 29(3):333-41. PubMed ID: 6189241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis.
    Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T
    Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
    Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
    Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
    van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
    Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage.
    Librenti MC; D'Angelo A; Micossi P; Garimberti B; Mannucci PM; Pozza G
    Acta Diabetol Lat; 1985; 22(1):39-45. PubMed ID: 2408434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet alpha granule release in diabetes mellitus.
    Sacchi S; Curci G; Piccinini L; Cucci F; Messerotti A; Roncaia R; Benedetti PG
    Scand J Clin Lab Invest; 1985 Apr; 45(2):165-8. PubMed ID: 2408317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients.
    Davì G; Rini GB; Averna M; Novo S; Di Fede G; Mattina A; Notarbartolo A; Strano A
    Haemostasis; 1982; 12(3):275-81. PubMed ID: 6183173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.